Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06548048Not ApplicableRecruiting

Dietary Supplementation on Fat Oxidation

Role: lead

NCT06417840Not ApplicableRecruiting

To Evaluate the Impact of Consumption of a Bioactive Compound on Fasting Blood Glucose Levels in Asian Indians With Pre-diabetes

Role: lead

NCT06454773Phase 3Recruiting

To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood Glucose Levels in People With Pre-diabetes: A Randomized Placebo-Controlled Parallel Arm Trial

Role: collaborator

NCT06296251Not ApplicableRecruiting

Dietary Supplementation on Body Fat Composition

Role: lead

NCT06262880Not ApplicableRecruiting

Dietary Supplementation on Gastrointestinal Barrier Function

Role: lead

NCT06098001Not ApplicableUnknown

Bioavailability Study of Hemp Phenolics

Role: lead

All 6 trials loaded